TEVA vs. VKTX
TEVA (Teva Pharmaceutical Industries Limited) and VKTX (Viking Therapeutics, Inc.) are both stocks. Both are in the Healthcare sector — TEVA in Drug Manufacturers - Specialty & Generic, VKTX in Biotechnology. Over the past 10 years, TEVA returned -4.15%/yr vs 36.31%/yr for VKTX. At a 0.24 correlation, their price movements are largely independent.
Performance
TEVA vs. VKTX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, TEVA achieves a 6.57% return, which is significantly higher than VKTX's -16.88% return. Over the past 10 years, TEVA has underperformed VKTX with an annualized return of -4.15%, while VKTX has yielded a comparatively higher 36.31% annualized return.
TEVA
- 1D
- -2.72%
- 1M
- -6.91%
- YTD
- 6.57%
- 6M
- 17.40%
- 1Y
- 87.17%
- 3Y*
- 65.55%
- 5Y*
- 25.39%
- 10Y*
- -4.15%
VKTX
- 1D
- 2.78%
- 1M
- -6.67%
- YTD
- -16.88%
- 6M
- -23.01%
- 1Y
- 5.07%
- 3Y*
- 6.41%
- 5Y*
- 39.22%
- 10Y*
- 36.31%
TEVA vs. VKTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
TEVA Teva Pharmaceutical Industries Limited | 6.57% | 41.61% | 111.11% | 14.47% | 13.86% | -16.99% | -1.53% | -36.45% | -18.63% | -46.18% |
VKTX Viking Therapeutics, Inc. | -16.88% | -12.57% | 116.23% | 97.98% | 104.35% | -18.29% | -29.80% | 4.84% | 88.42% | 241.18% |
Correlation
The correlation between TEVA and VKTX is 0.26, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.26 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.25 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.26 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.27 |
Correlation (All Time) Calculated using the full available price history since Apr 29, 2015 | 0.24 |
Fundamentals
TEVA:
$39.21B
VKTX:
$3.38B
TEVA:
$1.34
VKTX:
-$4.16
TEVA:
4.76
VKTX:
6.73
TEVA:
$17.35B
VKTX:
$0.00
TEVA:
$9.03B
VKTX:
-$208.00K
TEVA:
$3.05B
VKTX:
-$501.77M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TEVA vs. VKTX — Risk / Return Rank
TEVA
VKTX
TEVA vs. VKTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Teva Pharmaceutical Industries Limited (TEVA) and Viking Therapeutics, Inc. (VKTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| TEVA | VKTX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.18 | ||
| Sortino ratioReturn per unit of downside risk | +2.78 | ||
| Omega ratioGain probability vs. loss probability | 1.43 | 1.10 | +0.34 |
| Calmar ratioReturn relative to maximum drawdown | 4.02 | 0.11 | +3.91 |
| Martin ratioReturn relative to average drawdown | 10.94 | 0.23 | +10.71 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| TEVA | VKTX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.25 | 0.07 | +2.18 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.59 | 0.39 | +0.21 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.09 | 0.38 | -0.46 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.31 | 0.11 | +0.20 |
Drawdowns
TEVA vs. VKTX - Drawdown Comparison
The maximum TEVA drawdown since its inception was -90.89%, roughly equal to the maximum VKTX drawdown of -90.41%. Use the drawdown chart below to compare losses from any high point for TEVA and VKTX.
Loading charts...
Drawdown Indicators
| TEVA | VKTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -90.89% | -90.41% | -0.48% |
Max Drawdown (1Y)Largest decline over 1 year | -21.79% | -45.14% | +23.35% |
Max Drawdown (3Y)Largest decline over 3 years | -43.70% | -78.86% | +35.16% |
Max Drawdown (5Y)Largest decline over 5 years | -43.70% | -78.86% | +35.16% |
Max Drawdown (10Y)Largest decline over 10 years | -88.41% | -89.26% | +0.85% |
Current DrawdownCurrent decline from peak | -50.84% | -69.06% | +18.22% |
Average DrawdownAverage peak-to-trough decline | -32.00% | -60.02% | +28.02% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.00% | 22.54% | -14.54% |
Volatility
TEVA vs. VKTX - Volatility Comparison
The current volatility for Teva Pharmaceutical Industries Limited (TEVA) is 9.18%, while Viking Therapeutics, Inc. (VKTX) has a volatility of 14.20%. This indicates that TEVA experiences smaller price fluctuations and is considered to be less risky than VKTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| TEVA | VKTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.18% | 14.20% | -5.02% |
Volatility (6M)Calculated over the trailing 6-month period | 23.54% | 40.45% | -16.91% |
Volatility (1Y)Calculated over the trailing 1-year period | 38.97% | 74.12% | -35.15% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 42.94% | 101.63% | -58.69% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 47.34% | 97.07% | -49.73% |
Dividends
TEVA vs. VKTX - Dividend Comparison
Neither TEVA nor VKTX has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
TEVA Teva Pharmaceutical Industries Limited | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3.88% | 3.19% | 1.77% |
VKTX Viking Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
TEVA vs. VKTX - Financials Comparison
This section allows you to compare key financial metrics between Teva Pharmaceutical Industries Limited and Viking Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
TEVA and VKTX have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
VKTX has higher volatility (14.20%) compared to TEVA (9.18%). In terms of maximum drawdown, TEVA dropped -90.89% vs VKTX's -90.41%.
TEVA currently has the higher Sharpe Ratio (2.25 vs 0.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for TEVA and VKTX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer